论文部分内容阅读
七十年代以来,国内试制成功的 A 群流脑多糖体菌苗,初步汪明是安全有效的,为流脑的特异性预防开拓了新的途径。我们于1982年1月在安溪县13个社镇,川北京生物制品研究所提供的冻干 A 群流脑多糖体菌苗,对6个月至15岁儿童79,022人进行了接种反应与免疫效果观察,证实菌苗安全有效。为了解该菌苗的免疫持久性,探讨其免疫程序,在上述人群免疫甚础上,观察了免疫后连续二年的血清学和流行病学效果,现报告如下。
Since the 1970s, the trial-run A group of cerebrospinal-cerebrospiral bacteria vaccine, preliminary Wang Ming is safe and effective, opened up new avenues for the specific prevention of meningitis. In January 1982, we carried out the vaccination and immunization of 79,022 children from 6 months to 15 years of age in the lyophilized group A cerebrosphatemiae vaccine provided by 13 communities, ChuanBeijing Biologics Institute in Anxi County Observe that the vaccine is safe and effective. In order to understand the immune persistence of the vaccine, to explore its immune program, in the immunization of the above population, observed for two consecutive years after the serological and epidemiological effects, are as follows.